Dr. A K. Ritchey

Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease. Dr. Hillery is highly rated in 6 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Steven Fein, MD, specializes in hematology oncology and is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine by the American Board of Internal Medicine. He practices at University of Pittsburgh Physicians, Department of Hematology Oncology. Dr. Fein completed his fellowship at University of Miami Miller School of Medicine at Jackson Memorial Hospital, residency at Duke University Medical Center, and medical education at Johns Hopkins University School of Medicine. Dr. Fein is highly rated in 32 conditions, according to our data. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology. Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis. He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health. Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection. View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is highly rated in 5 conditions, according to our data. His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).